NASDAQ:EYE

National Vision Holdings Stock News

etoro logo Buy EYE
*Your capital is at risk
$16.78
-0.180 (-1.06%)
At Close: Jun 23, 2026
National Vision's (EYE) higher SG&A expenses in the third quarter reflect increases in performance-based incentives and stock-based compensations.
National Vision Holdings, Inc. (NASDAQ:EYE ) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Caitlin Churchill - IR Reade Fahs - CEO Melissa Rasmussen - CFO Patrick M
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Investors with an interest in Medical - Products stocks have likely encountered both National Vision (EYE) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
Investors are optimistic about National Vision's (EYE) stock, banking on comparable store sales growth and stable liquidity.
In terms of store expansion, National Vision (EYE) continues to see a sizable new opportunity with growth for the coming years.
Investors need to pay close attention to National Vision (EYE) stock based on the movements in the options market lately.
National Vision's (EYE) second-quarter 2023 performance highlights positive comparable store sales growth, retention and recruitment trends.
National Vision Holdings, Inc. (NASDAQ:EYE ) Q2 2023 Earnings Conference Call August 10, 2023 8:30 AM ET Company Participants Angie McCabe - IR Reade Fahs - CEO, President & Director Melissa Rasmussen
Although the revenue and EPS for National Vision (EYE) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall S
Investors are optimistic about National Vision's (EYE) stock, banking on comparable store sales growth and technological investments.
National Vision (EYE) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year ago.
National Vision (EYE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
National Vision (EYE) continues to roll out its remote care capabilities, which provide doctors with additional levels of flexibility and expand exam capacity in many areas.
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EYE, CAH and HSIC are poised ahead of their earnings releases.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE